Get started
Work

Supplementary Figure S1 from Determinants of Response to Sequential Pembrolizumab with Trastuzumab plus Platinum/5-FU in HER2-Positive Gastric Cancer: A Phase II Chemoimmunotherapy Trial

Year: 2026
Type: supplementary-materials
Abstract: Progression free and overall survival in a frontline phase II sequential chemoimmunotherapy trial in HER2+ GC.
DOI: 10.1158/1078-0432.32712516
Authors: Sung Hee Lim, Minae An, Hyuk Lee, You Jeong Heo, Byung-Hoon Min, Arnav Mehta, Samuel Wright, Kyoung-Mee Kim, Seung Tae Kim, Samuel J. Klempner, Jeeyun Lee
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W7165003886
Cites:
Cited by:
Related to: 10